Robert A Hauser Selected Research

Dyskinesias (Dyskinesia)

3/2022	Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease.
1/2022	Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study.
1/2022	Potential utility of amantadine DR/ER in persons with Parkinson's disease meeting 5-2-1 criteria for device aided therapy.
1/2022	Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine.
1/2022	Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
12/2021	Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia.
11/2021	Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.
6/2021	Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia.
1/2021	Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.
1/2021	Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Hauser Research Topics

Disease

133	Parkinson Disease (Parkinson's Disease) 03/2022 - 05/2000
59	Dyskinesias (Dyskinesia) 03/2022 - 08/2003
14	Dizziness (Lightheadedness) 01/2020 - 11/2008
13	Tremor (Tremors) 01/2022 - 07/2002
13	Nausea 01/2020 - 08/2003
12	Orthostatic Hypotension (Postural Hypotension) 03/2022 - 07/2004
12	Tardive Dyskinesia 01/2022 - 10/2015
11	Parkinsonian Disorders (Parkinsonism) 01/2022 - 07/2005
11	Torticollis (Wryneck) 01/2022 - 09/2004
11	Sleepiness 01/2020 - 01/2003
10	Disease Progression 01/2021 - 05/2000
9	Movement Disorders (Movement Disorder) 01/2022 - 01/2007
9	Essential Tremor (Essential Tremors) 07/2012 - 05/2005
7	Constipation 01/2020 - 01/2006
7	Chorea (Rheumatic Chorea) 03/2008 - 06/2005
6	Hallucinations (Hallucination) 01/2020 - 07/2004
6	Huntington Disease (Huntington's Disease) 01/2016 - 06/2002
5	Headache (Headaches) 11/2018 - 04/2010
4	Dystonia (Limb Dystonia) 01/2022 - 12/2004
4	Edema (Dropsy) 01/2022 - 07/2004
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 11/2002
4	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2020 - 03/2011
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2021 - 01/2010
3	Disorders of Excessive Somnolence (Hypersomnia) 10/2021 - 01/2003
3	Hypokinesia (Bradykinesia) 01/2021 - 01/2009
3	Hypertension (High Blood Pressure) 12/2018 - 08/2016
3	Multiple System Atrophy 04/2017 - 03/2014
2	Psychomotor Agitation (Akathisia) 01/2022 - 01/2018
2	Dementia (Dementias) 01/2021 - 08/2014
2	Pure Autonomic Failure 04/2017 - 08/2016
2	Wounds and Injuries (Trauma) 09/2016 - 01/2014
2	Cognitive Dysfunction 08/2016 - 01/2016
2	Fatigue 11/2013 - 11/2010
2	Deglutition Disorders (Dysphagia) 02/2013 - 09/2012
2	Myoclonus (Nocturnal Myoclonus) 07/2007 - 11/2002
1	Mental Disorders (Mental Disorder) 01/2022

Drug/Important Bio-Agent (IBA)

74	Levodopa (L Dopa)FDA LinkGeneric 03/2022 - 05/2000
16	Amantadine (Aman)FDA LinkGeneric 03/2022 - 03/2013
12	rasagiline (Azilect)FDA Link 01/2022 - 08/2004
11	Carbidopa (Lodosyn)FDA LinkGeneric 01/2020 - 05/2000
10	Dopamine Agonists (Dopamine Agonist)IBA 11/2021 - 01/2003
9	DroxidopaIBA 03/2022 - 01/2014
9	Pharmaceutical PreparationsIBA 01/2022 - 05/2014
9	Pramipexole (Mirapex)FDA LinkGeneric 01/2022 - 12/2006
9	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 12/2020 - 03/2009
9	Levetiracetam (Keppra)FDA LinkGeneric 09/2008 - 12/2004
8	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 10/2015
8	Dopamine (Intropin)FDA LinkGeneric 11/2018 - 07/2003
7	abobotulinumtoxinA FDA Link 01/2021 - 07/2005
7	ropinirole (Requip)FDA LinkGeneric 05/2011 - 07/2003
6	deutetrabenazineIBA 01/2022 - 01/2017
6	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 07/2009
6	istradefyllineIBA 01/2021 - 08/2003
6	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2012
5	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 11/2020 - 03/2011
5	Type A Botulinum Toxins (Botox)FDA Link 01/2020 - 09/2004
5	SynucleinsIBA 01/2019 - 01/2012
5	entacapone (Comtan)FDA Link 07/2009 - 01/2004
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 07/2002
4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2021 - 08/2003
4	valbenazineIBA 01/2018 - 10/2015
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2017 - 01/2014
4	ProdrugsIBA 04/2017 - 01/2014
4	StalevoIBA 07/2009 - 01/2004
3	AntiemeticsIBA 01/2022 - 11/2014
3	Apomorphine FDA Link 01/2020 - 11/2014
3	Dopa DecarboxylaseIBA 01/2019 - 05/2007
3	Dopamine Agents (Dopaminergic Agents)IBA 11/2018 - 07/2009
3	CreatineIBA 04/2017 - 09/2015
3	Caffeine (No Doz)FDA LinkGeneric 04/2017 - 07/2008
3	Topiramate (Topamax)FDA LinkGeneric 01/2017 - 04/2006
3	ioflupaneIBA 08/2014 - 11/2013
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2014
2	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 11/2002
2	Carboxy-LyasesIBA 01/2021 - 12/2007
2	PowdersIBA 12/2020 - 01/2019
2	tozadenantIBA 11/2020 - 08/2014
2	Isradipine (Dynacirc)FDA LinkGeneric 11/2020 - 01/2017
2	TabletsIBA 01/2019 - 01/2014
2	Monoamine Oxidase (MAO)IBA 01/2017 - 05/2007
2	TEMPOIBA 10/2016 - 06/2010
2	mavoglurantIBA 01/2016 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 01/2012
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2014 - 07/2012
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2013 - 05/2008
2	Delayed-Action PreparationsIBA 04/2013 - 10/2011
2	pardoprunoxIBA 07/2011 - 04/2010
2	Selegiline (E250)FDA LinkGeneric 01/2010 - 04/2004
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2007 - 05/2006
2	Prostaglandins BIBA 08/2007 - 01/2007
2	Pregabalin (Lyrica)FDA Link 08/2007 - 01/2007
2	Neuroprotective AgentsIBA 05/2007 - 05/2000
2	Bromocriptine (Parlodel)FDA LinkGeneric 09/2002 - 05/2000

Therapy/Procedure

33	Therapeutics 01/2022 - 07/2004
7	Activities of Daily Living (ADL) 01/2017 - 12/2007
6	Injections 01/2021 - 07/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2017
5	Deep Brain Stimulation 01/2021 - 04/2006
4	Transplantation 02/2013 - 06/2002